These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3097700)

  • 21. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine.
    Ogren SO
    Brain Res Bull; 1986 May; 16(5):645-60. PubMed ID: 3742248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape performance after inescapable shock in selectively bred lines of mice: response maintenance and catecholamine activity.
    Anisman H; Grimmer L; Irwin J; Remington G; Sklar LS
    J Comp Physiol Psychol; 1979 Apr; 93(2):229-41. PubMed ID: 457947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic pharmacology of p-chloroamphetamine, a serotonin agonist, in conscious rats.
    Alper RH; Lee C; Brody MJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):446-54. PubMed ID: 3681694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock.
    Shanks N; Anisman H
    Psychopharmacology (Berl); 1989; 99(1):122-8. PubMed ID: 2506597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition and retention of enhanced active avoidance are unaffected by interference with serotonergic activity.
    Galindo LE; Garín-Aguilar ME; Medina AC; Serafín N; Quirarte GL; Prado-Alcalá RA
    Behav Brain Res; 2008 Dec; 195(1):153-8. PubMed ID: 18342379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term biochemical and behavioral effects of p-chloroamphetamine in the rat.
    Köhler C; Ross SB; Srebro B; Ogren SO
    Ann N Y Acad Sci; 1978 Jun; 305():645-63. PubMed ID: 280260
    [No Abstract]   [Full Text] [Related]  

  • 28. Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress.
    Anisman H; Irwin J; Sklar LS
    Psychopharmacology (Berl); 1979 Aug; 64(2):163-70. PubMed ID: 115036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal effects of p-chloroamphetamine on catecholamine synthesis.
    Steranka L; Sanders-Bush E
    Eur J Pharmacol; 1977 Sep; 45(1):83-6. PubMed ID: 891623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective lesions of the bulbospinal serotonergic pathways reduce the analgesia induced by p-chloroamphetamine in the hot-plate test.
    Berge OG; Ogren SO
    Neurosci Lett; 1984 Jan; 44(1):25-9. PubMed ID: 6717848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception.
    Ogren SO; Berge OG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):135-40. PubMed ID: 4010792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal application of p-chloroamphetamine or fenfluramine reduces response selection during early ontogenetic development of rat avoidance behaviour.
    Köllner O; Köllner U; Göb R; Klingberg F
    Biomed Biochim Acta; 1988; 47(12):997-1005. PubMed ID: 3254160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    Yamada J; Sugimoto Y; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock.
    Anisman H; Sklar LS
    J Comp Physiol Psychol; 1979 Aug; 93(4):610-25. PubMed ID: 573289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effect of p-chloroamphetamine on individual catecholaminergic nuclei in the rat brain.
    Massari VJ; Tizabi Y; Jacobowitz D
    Eur J Pharmacol; 1978 Aug; 50(3):279-82. PubMed ID: 689081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test-dependent variations in the antinociceptive effect of p-chloroamphetamine-induced release of 5-hydroxytryptamine.
    Ogren SO; Berge OG
    Neuropharmacology; 1984 Aug; 23(8):915-24. PubMed ID: 6237274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
    Orikasa S; Sloley BD
    Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin and fear retention in the rat.
    Archer T
    J Comp Physiol Psychol; 1982 Jun; 96(3):491-516. PubMed ID: 7096685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.